logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Sunday, June 7, 2026 · 917,954,805 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Lymphoma Drugs News Monitoring

  • Published on Jun 6, 2026

    Reid Hoffman to leave Microsoft board to focus on AI drug discovery startup Manas AI

    The LinkedIn co-founder is stepping away from one of tech's most powerful board seats to go full 'founder mode' on an AI company hunting for cancer treatments. Reid Hoffman, the venture capitalist and LinkedIn co-founder who has sat on …

    Source: Crypto Briefing - Neutral
  • Published on Jun 6, 2026

    Experts call for frog poison detox drug that killed British man to be banned amid warnings it will claim more lives

    A group of toxicology and forensic medicine experts have urged for a ban on the frog poison 'detox' drug that claimed the life of a British man.  Kristian Trend, 40, died in April after using Kambo, a drug made from the secretion of an amphibian …

    Source: Daily Mail - Right-wing
  • Published on Jun 6, 2026

    Ban frog poison detox drug, say medical experts

    A “detox” treatment using a drug made from an Amazonian tree frog must be banned, medical experts have warned. The group of specialists in toxicology and forensic medicine has urged governments and health authorities to treat the drug Kambo – which claimed …

    Source: Yahoo News - Center-left
  • Published on Jun 6, 2026

    Sanofi Eczema Drug Suits Consolidated, Sent To NJ Fed Court

    By Emily Field ( June 5, 2026, 5:35 PM EDT) -- The Judicial Panel on Multidistrict Litigation has sent to federal court in New Jersey suits against Regeneron Pharmaceuticals and Sanofi-Aventis alleging the eczema drug Dupixent causes a rare type of non- …

    Source: Law360 - Neutral
  • Published on Jun 4, 2026

    ADC Therapeutics nosedives on 27 deaths in confirmatory trial for lymphoma drug

    There were thrice as many deaths in patients treated with ADC Therapeutics’ lymphoma drug Zynlonta as in controls given standard immunotherapy, causing the biotech’s share price to crash more than 50% to $1.44 per share and potentially complicating the …

    Source: BioSpace - Pending
  • Published on Jun 5, 2026

    'Out of options': Cancer patient seeks $200k treatment in China

    Wortman-Dabrowska saw her doctor. Blood tests revealed she had multiple myeloma, which was causing her bones to deteriorate, she said. She had chemotherapy and a stem cell transplant. Doctors then found a “big hole” in her right femur bone, which required …

    Source: Bay of Plenty Times - Neutral
  • Published on Jun 6, 2026

    A wish to help others in need

    Thirteen-year-old Isaac Stanley had a wish that was set to benefit him, but also give back to others. The teen has been battling primary mediastinal B-cell lymphoma since diagnosed last year. He was given a 3D printer by Make A Wish New Zealand. It was …

    Source: Ashburton Courier - Neutral
  • Published on Jun 3, 2026

    Avammune’s big bet: Why the future of cancer treatment may come in a pill

    In the fight against cancer, CAR-T therapy and checkpoint inhibitors are two powerful types of immunotherapies that help the immune system fight cancer. CAR-T is like a custom-made special forces team. Doctors take a patient’s own T-cells (killer immune …

    Source: The Economic Times - Center-right
  • Published on Jun 4, 2026

    ADC Therapeutics slumps on cancer drug safety scare

    Shares in ADC Therapeutics were trading down more than 50% today after a non-Hodgkin lymphoma (NHL) trial showed more deaths with its Zynlonta drug compared to standard therapy. The LOTIS-5 trial is designed as a confirmatory study to upgrade Zynlonta' …

    Source: pharmaphorum - Neutral
  • Published on Jun 4, 2026

    An ADC specialist sinks on safety concerns for blood cancer drug

    ADC Therapeutics said its blood cancer drug met the main goal of a confirmatory trial, but the experiment recorded more deaths among patients treated with the drug, sending shares down more than 50% Thursday morning. The Switzerland-based company unveiled …

    Source: BioPharma Dive - Pending
  • Published on Jun 4, 2026

    ‘Incredible’ Hodgkin Lymphoma Clinical Trial Study

    Epworth Pictured: Tomas participated in the clinical trial at Epworth. Three young Victorians involved in a clinical trial of a new treatment for early-stage Hodgkin lymphoma all remain in remission with no cancer detected around three years on. As part of …

    Source: The National Tribune - Center-left
  • Published on Jun 4, 2026

    FDA Expands Dupixent Use as Questions About Rare Lymphoma Continue

    The U.S. Food and Drug Administration (FDA) has continued expanding the role of Dupixent (dupilumab) in treating inflammatory diseases. In recent months, the agency cleared the medication for allergic fungal rhinosinusitis (AFRS) in adults and children …

    Source: The Legal Examiner - Florida - Neutral
  • Published on Jun 4, 2026

    China approves innovative tumor-targeted drug for lymphoma patients

    GUANGZHOU, June 4 (Xinhua) -- Rocbrutinib, a new targeted anti-cancer drug, received marketing approval on Thursday from China's National Medical Products Administration (NMPA). This revolutionary drug offers new treatment opportunities for lymphoma …

    Source: Xinhua News Agency - Gov't Propaganda
  • Published on Jun 4, 2026

    ADC Therapeutics plunges after patient deaths in blood cancer drug trial

    June 4 (Reuters) - ADC Therapeutics shares slumped nearly 53% in premarket trading on Thursday after a late-stage study testing its blood cancer drug ‌showed more deaths among treated patients, despite meeting its main goal of ‌improving progression-free …

    Source: Yahoo Finance - Center-left
  • Published on Jun 6, 2026

    Casa Museo de Raphael opens in Linares with the artist’s unique collection

    In Linares (Jaén province, Andalusia), the Casa Museo de Raphael has officially opened, dedicated to the life and work of one of Spain’s most renowned performers. The exhibition is housed in the El Pósito building, constructed in the 18th century, which …

    Source: RUSSPAIN - Pending
  • Published on Jun 3, 2026

    Legend surges on early data for ‘in vivo’ lymphoma cell therapy

    Dive Brief: An experimental cancer cell therapy developed by Legend Biotech helped reduce or eliminate signs of disease in people with lymphoma enrolled in a clinical trial, sparking hopes the “in vivo” medicine might compete with personalized, marketed …

    Source: BioPharma Dive - Pending
  • Published on Jun 4, 2026

    Researchers Aim to Expand Horizons of CAR T-cell Treatment

    BYLINE: Kristi Birch Newswise — It’s been nearly 10 years since the U.S. Food and Drug Administration (FDA) approved the first chimeric antigen receptor T-cell (CAR-T) therapy to treat a type of leukemia. Today, there are seven FDA-approved CAR T-cell …

    Source: Newswise - Neutral
  • Published on Jun 3, 2026

    Family requests help to cover treatment costs for a patient with lymphoma

    Santo Domingo.– The family of Manuel de Regla Arias Martínez has called for the public’s solidarity to help cover the medical treatment he urgently needs due to lymphoma, a type of cancer that affects the lymph nodes. According to his wife, Yomari de Jesús …

    Source: De Último Minuto - Neutral
  • Published on Jun 4, 2026

    Thousands of Leukemia patients have only four specialists for BMT treatment

    Mirror AI Summary – Quick Read Generated by Mirror AI MIRROR AI Hide ⏳ Generating summary… AI SUMMARY GENERATED ONLY FROM THIS ARTICLE'S TEXT. In Sri Lanka, between 15, 000 to 18, 000 cancer cases are reported annually, around 1, 500 to 2,000 of them …

    Source: Daily Mirror - Neutral

24 days 17:00:00

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 917,954,805 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/13/2026

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow EIN Presswire on Facebook, LinkedIn and Substack

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2026 Newsmatics Inc. · All Rights Reserved · General Terms & Conditions · Privacy Policy · Cookie Settings

By continuing to use this site, you agree to our Terms & Conditions, last updated on September 30, 2025.